Eliciting health state utilities from the general public for severe chronic pain
作者： S. Eldabe , A. Lloyd , L. Verdian , M. Meguro , G. Maclaine
DOI: 10.1007/S10198-009-0178-X
关键词:
摘要: There is an absence of data on public preferences for health states (HSs) associated with severe chronic pain. The aim this study was to develop accurate HS descriptions pain requiring intrathecal (IT) therapy and derive utility weights that describe the health-related quality life (HRQL) impact malignant (MP) non-malignant (NMP) aetiologies. Eight visual analogue scale index (VAS-PI) HSs were defined using ranges 0–40, 41–60, 61–80 81–100 applied both MP NMP. Additionally, eight representing common adverse events IT identified. content description ascertained by interviews five United Kingdom clinical experts. In total, 16 compiled. These questionnaires administered 102 members public, utilising a time trade off (TTO) approach estimate utilities HSs. Participants generally well matched general in England Wales, some differences mean age, race education. A substantial decline observed more VAS-PI values. TTO values also decreased from mild able differentiate between side effects. shows clear decrement moving different severity levels
springer.com
jstor.org 
sci-hub.se 参考文章(36)
Hoare, Li Wan Po, Williams, Systematic review of treatments for atopic eczema Health Technology Assessment. ,vol. 4, pp. 1- 191 ,(2000) , 10.3310/HTA4370
UNAL TUTAK, DANIEL M. DOLEYS, Intrathecal Infusion Systems for Treatment of Chronic Low Back and Leg Pain of Noncancer Origin Southern Medical Journal. ,vol. 89, pp. 295- 300 ,(1996) , 10.1097/00007611-199603000-00007
Bert Spilker, Quality of life and pharmacoeconomics in clinical trials Lippincott-Raven. ,(1996)
Claus Naumann, Serdar Erdine, Athanasios Koulousakis, Jean-Pierre Buyten, Marilee Schuchard, Drug adverse events and system complications of intrathecal opioid delivery for pain: origins, detection, manifestations, and management. Neuromodulation. ,vol. 2, pp. 92- 107 ,(2002) , 10.1046/J.1525-1403.1999.00092.X
Saadat Kamran, Ballard D. Wright, Complications of intrathecal drug delivery systems. Neuromodulation. ,vol. 4, pp. 111- 115 ,(2001) , 10.1046/J.1525-1403.2001.00111.X
Mark S. Wallace, Richard Rauck, Robert Fisher, Steven G. Charapata, David Ellis, Sanjeeva Dissanayake, Intrathecal ziconotide for severe chronic pain: safety and tolerability results of an open-label, long-term trial. Anesthesia & Analgesia. ,vol. 106, pp. 628- 637 ,(2008) , 10.1213/ANE.0B013E3181606FAD
Kenny C. Lai, James M. Provenzale, David Delong, Srinivasan Mukundan, Assessing patient utilities for varying degrees of low back pain Academic Radiology. ,vol. 12, pp. 467- 474 ,(2005) , 10.1016/J.ACRA.2004.11.031
A. M. Elliott, B. H. Smith, P. C. Hannaford, W. C. Smith, W. A. Chambers, The course of chronic pain in the community: results of a 4-year follow-up study. Pain. ,vol. 99, pp. 299- 307 ,(2002) , 10.1016/S0304-3959(02)00138-0
Laurie L. Ackerman, Kenneth A. Follett, Richard W. Rosenquist, Long-term outcomes during treatment of chronic pain with intrathecal clonidine or clonidine/opioid combinations Journal of Pain and Symptom Management. ,vol. 26, pp. 668- 677 ,(2003) , 10.1016/S0885-3924(03)00144-1
S. Mercadante, Controversies over spinal treatment in advanced cancer patients Supportive Care in Cancer. ,vol. 6, pp. 495- 502 ,(1998) , 10.1007/S005200050204